Caray, Baby Girl .

HRN: 21-99-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/20/2022
11/27/2022
IV
50 Mg
Q24
PSNB (Maternal UTI, Chorioamnionitis) RDS Vs MAS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: